Field note · October 2026

The hiring order inside a warning letter

A warning letter reads like a punishment. Read it a second time and it is closer to a purchase order.

In September the agency wrote to a sterile manufacturing site in Florida. The findings had the usual shape: out-of-limit microbial recoveries in the aseptic core, process simulations too small to represent the commercial batches they were meant to model, a quality unit that had not exercised oversight. Then came the line that actually matters. Evaluate the airflow in your aseptic process, the agency wrote, with the assistance of a qualified consultant.

That is not a reprimand. It is a specification. A federal regulator has stated in writing that the expertise needed to close this finding does not currently exist inside that building.

The agency does not write job descriptions. It just describes, with precision, the person the company does not have.

And the firms that receive these letters are, by construction, the ones least able to answer them. A quality unit that lacked the standing to halt a release last year does not acquire that standing in the fifteen working days it now has to respond. The gap the inspector found and the gap in the org chart are the same gap. That is why the remedy keeps arriving in the language of outside help.

So the window is narrow and it is predictable. The letter publishes, the response clock starts, and for a few weeks a firm that has never thought about contract quality leadership becomes the most motivated buyer of it in the country. Almost nobody is in the room at that moment. The people who could fix it are mid-contract somewhere else, and the firm is still drafting its reply. Standing in that gap, with a name ready, is the entire job.

— Lucken Gherca routes quality and validation operators into FDA-regulated sites working an open finding.